Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

(18F)Fluoro-deoxy-D-glucose uptake of knee joints in the aspect of age-related osteoarthritis: a case-control study

BMC Musculoskeletal DisordersBMC series – open, inclusive and trusted201314:141

DOI: 10.1186/1471-2474-14-141

Received: 2 November 2012

Accepted: 18 April 2013

Published: 22 April 2013

Abstract

Background

This study investigated 18F-fluorodeoxyglucose (18F-FDG) uptake at knee joints for determination of metabolic alteration in association with the advance of age and joint degeneration such as osteoarthritis (OA).

Methods

A total of 166 knees from 83 healthy persons who presented for routine health examination and positron emission tomography-computed tomography (PET/CT) were enrolled in this study. History of knee OA and joint symptoms and signs were reviewed. The maximum standardized uptake values (SUVmax) of cartilage and mean SUV (SUVmean) between the epiphyseal plates of femur and tibia were evaluated at knee joints. Assessment of radiological bony changes was performed using the Kallgren-Lawrence (K/L) grading system with reconstructed CT images of the knee. The joint symptoms and signs were counted and used for diagnosis of clinical and radiological OA of the knee.

Results

The SUVmean of the knee joints showed a remarkable increase with aging in females (r = 0.503, p < 0.01). Remarkable changes of SUVmean were observed with history of OA (p < 0.01). The SUVmean of joint and the intra-articular SUVmax showed higher values in clinical and radiological OA than in normal joints (p < 0.01). Joint-SUVmean showed significant correlation with OA severity graded according to K/L score (p < 0.05). The intra-articular SUVmax showed a significant increase in symptomatic joints, indicating OA in correlation with the joint-SUVmean (p = 0.01).

Conclusions

The increasing 18F-FDG uptakes of knee joints showed agreement with aging in females and clinical and radiological knee OA, indicating that the metabolic alterations were consistent with diagnosis and demographic aspect of OA as a surrogate marker for degeneration of the knee in association with aging.

Keywords

F-FDG PET Aging Osteoarthritis

Background

OA is usually characterized by painful joints, which may accompany subchondral sclerosis, joint space narrowing, and osteophytosis in association with cartilage degeneration. These changes may lead to joint destruction, loss of joint function, and joint failure. Aging is the most important risk factor for primary OA not caused by injury or disease, and almost 80% of people older than 75 years of age present with OA, one of the most commonly occurring diseases in the elderly [1]. However, it remains unclear what occurs in the joints with aging and how aging affects the joints and elicits OA.

Regarding the pathogenesis of OA, it is generally accepted that if physical stress to a joint is sufficient to denature articular cartilage matrix, synthesis of proteoglycans and collagen decreases, making the joint vulnerable to stress [2]. As cartilage wears out, increased stress to the joint may lead to development of a micro-fracture in the subchondral bone. Healing processes following micro-fracture result in bony sclerosis and stiffness, compromising capacity to resolve stress. In a vicious manner, the insulted joints fall into irreversible progression to overt OA [3]. However, metabolic alterations in cartilage may be associated with vulnerability of the joint to stress in primary OA, and certain cellular processes that occur during aging may contribute to development of OA [4].

18F-FDG is one of the most popular radiopharmaceuticals used for PET scans and 18F-FDG uptake has been reported to be highly sensitive in detection of metabolic alterations in some skeletal disorders [58]. Intra-articular SUVmax and joint-SUVmean of 18F-FDG on PET/CT were measured and calculated at knees for determination of metabolic changes of the joints in association with aging, grade of bony changes, and presence of clinico-laboratory and radiological knee OA, as defined by the American College of Rheumatology (ACR).

Methods

This study was designed to evaluate changes of 18F-FDG uptake on PET and K/L grades on CT in 166 knee joints from 83 healthy persons (42 males and 41 females). The study was conducted according to the code of ethics of the World Medical Association (Declaration of Helsinki) and all of the procedures followed were approved by the ethical committee of Yeungnam University Medical Center.

Case procurement

All cases presenting for routine medical examination and whole body fusion PET/CT between 2004 and 2010 were subjected to this study, regardless of joint problems. Any case showing abnormalities on laboratory tests, such as a high erythrocyte sedimentation rate (ESR) and high rheumatoid factor (RF), history of diabetes, malignancy and joint trauma, including surgery, and other metabolic or inflammatory diseases was excluded prior to undergoing PET/CT. Medical history for knee OA was reviewed, and pain, stiffness, crepitus, bony tenderness, and enlargement of each knee were counted from 0 to 5 in total. Body weight, height, and body mass index (BMI) were measured for the standard uptakes of 18F-FDG and evaluated in terms of OA as well.

Integrated 18F-FDG PET/CT scan

All patients fasted for at least 6 h prior to undergoing PET/CT (DST or DVCT, GE Medical system, Milwaukee, USA). The serum glucose level was measured to ensure that the result was <200 mg/dL. Sixty to 90 minutes after intravenous injection of 8.14 MBq/kg of 18F-FDG, whole-body PET/CT scanning was performed. CT images (120 mAs, 140 kVp, and a section width of 3.75 mm) were acquired without breath-holding instructions. The PET emission scan was obtained immediately following acquisition of CT scan, without change in the patient’s position. Image acquisition for whole body PET/CT was performed separately from the vertex to the mid-thigh in eight to 10 bed positions, and then from mid-thigh to toe in five to six bed positions with an acquisition time of 2.5 to 3 min for each bed position. The attenuation corrected 18F-FDG-PET images were reconstructed using the CT data with an ordered-subset expectation maximization algorithm. The attenuation-corrected PET images, CT images, and fused PET/CT images displayed as coronal, sagittal, and trans-axial slices were viewed on a workstation (Advanced workstation 4.4, GE Healthcare). An experienced nuclear medicine physician, who was not aware of the patient’s clinical history or recent radiographic data, reviewed and interpreted the PET/CT images three times. For semi-quantitative analysis, the regions of interest (ROIs) were delineated on trans-axial images, and the maximum and mean standardized uptake values (SUVs) were calculated on the workstation. The SUVs were acquired using the attenuation-corrected images, the amount of injected 18F-FDG, body weight of each patient, and cross-calibration factors between 18F-FDG-PET and the dose calibrator.
SUV = ( decay - corrected measured activity [ mCi / g ] / ( administered dose mCi ) / patient weight [ g ] )
The average value and the highest value in the ROIs were defined as the SUVmean and SUVmax, respectively. Joint-SUVmean and intra-articular SUVmax were adopted in this study because discrimination of joint structures is difficult, and determining which structure is responsible for OA pathology is extremely difficult with PET and CT images. The joint-SUVmean was obtained from the minimal area between epiphyseal plates of femur and tibia, including intra-articular space and subchondral bones of knee joints (Figure 1A, green box). The highest 18F-FDG uptake of intra-articular space was determined as intra-articular SUVmax in the zone delineated by crooked lines within the green box for joint-SUVmean, which included cartilage, synoviums, ligaments, menisci, and synovial fluid, except for the epiphyseal parts of femur and tibia, and bony part of patella. Blue rectangles indicate the points of the highest SUV of the intra-articular space (Figure 1A).
https://static-content.springer.com/image/art%3A10.1186%2F1471-2474-14-141/MediaObjects/12891_2012_Article_1747_Fig1_HTML.jpg
Figure 1

Joint-SUVmean was measured at the ROIs indicated by the green boxes, which included the minimal area between the epiphyseal plates of the femur and tibia in the trans-axial, coronal, and sagittal planes. The blue rectangles indicate the points of the highest SUV of intra-articular space, the ROIs for intra-articular SUVmax are precisely delineated by crooked lines within the green box for joint-SUVmean. The point of intra-articular SUVmax was confirmed in trans-axial, coronal, and sagittal slices (A). Coronal-reconstruction CT images were arranged in the anterior-posterior view of knees for K/L grading (B).

CT image analysis

Non-contrast-enhanced CT images (120 mAs, 140 kVp) were acquired in helical mode with 3.75 mm slice thickness. As for knee joints, the tomographic CT images were reconstructed and assessed according to the procedures outlined by Johnston JD et al. [9]. All reconstructed CT images were evaluated in a blind manner by a PET/CT specialist in axial, coronal, and sagittal views for the presence and degree of joint space narrowing and osteophytes in medial-, lateral femorotibial joints and femoropatellar joint from the knee cap to popliteal fossa at an interval of 1 mm (Figure 1B). Intraobserver reliability was 0.78 with moderate agreement. Subsequently, joint space narrowing and osteophytosis were graded from 0–IV using the Kallgren-Lawrence (K/L) system [10]; no abnormal radiological finding was designated as grade 0; no joint space narrowing but suspicious osteophytes, grade I; minimal joint space narrowing and definite osteophytes, grade II; joint space less than 3 mm, severe intra-articular irregularity, and prominent osteophytes, grade III; no visible joint space and severe sclerosis, grade IV.

Statistical analysis

Statistical analysis was performed using SPSS program version 12. Cohen’s kappa test was used for determination of intraobserver variation. Independent sample t test, one way ANOVA test, Pearson’s correlation test, and Linear regression analysis were used for parametric analysis and Mann–Whitney test, Kruskal-Wallis test, and Spearman’s test were used for non-parametric analysis, with a confidence interval of 95% and a p value < 0.05.

Results

18F-FDG uptake and radiological OA of knee joints

Joint mean and intra-articular SUVmax on PET scan were evaluated according to K/L grade (Figure 1B). Thirty four knee joints were K/L grade 0, 61 were grade I, 38 were grade II, and 33 were grade III, and no cases of grade IV were observed. Mean age of each grade was 46.7±11.3 for grade 0, 55.1±11.5 for grade I, 58.6±10.5 for grade II, and 60.6±8.9 for grade III, respectively; significantly older mean age was observed with a higher grade of bony changes (p < 0.01). Body weight, height, and BMI did not differ among the groups. The mean and max SUV in the group of grade 0 were 1.42 ± 0.36 and 0.85 ± 0.18, respectively; 1.55 ± 0.45 and 0.88 ± 0.20, respectively, in grade I; 1.61 ± 0.58 and 0.96 ± 0.19, respectively, in grade II; 1.70 ± 0.51 and 0.97 ± 0.22, respectively, in grade III. Knees with a higher K/L grade showed higher joint-SUVmean; a significant increase of joint-SUVmean was observed among the groups (p < 0.05), but not for intra-articular SUVmax (Table 1).
Table 1

The joint-SUVmean and intra-articular SUVmax of the knees according to K/L grades

  

n

Age (yr)

BW (kg)

HT(cm)

BMI (kg/m2)

SUVmax

SUVmean

Knee joints

Total

166

55.3±11.7

62.7±11.7

162.9±8.6

23.5±3.2

1.58 ± 0.49

0.91 ± 0.20

 

Male

82

55.7 ± 12.1

69.3±11.1**

169.5±6.2**

24.1±3.1**

1.62 ± 0.48

0.94 ± 0.19*

 

Female

84

54.9 ± 11.4

56.1±8.2

156.6±5.2

22.9±3.3

1.53 ± 0.49

0.88 ± 0.20

K/L grade

0

34

46.7 ± 11.3

63.9±12.9

163.1±10.3

23.8±3.1

1.42 ± 0.36

0.85 ± 0.18

 

I

61

55.1 ± 11.5

62.1±10.4

162.8±7.9

23.3±3.1

1.55 ± 0.45

0.88 ± 0.20

 

II

38

58.6 ± 10.5

63.7±14.2

164.1±9.0

23.5±4.1

1.61 ± 0.58

0.96 ± 0.19

 

III

33

60.6 ± 8.9

61.3±9.7

161.8±7.4

23.3±2.7

1.70 ± 0.51

0.97 ± 0.22

 

IV

0

-

-

-

-

-

-

p-value

 

<0.01**

0.738

0.741

0.916

0.065

0.037*

value = mean ± SD.

BW; body weight, HT; height, BMI; body mass index.

*; p < 0.05, **; p < 0.01.

Knees with K/L grade 0 and I can be classified as non-OA radiographically, and the SUVmean and intra-articular SUVmax of the non-OA group (n = 95, 0.87±0.19 and 1.50±0.42, respectively) were compared with those of the radiological OA (K/L grade II, III, and IV [n = 71], 0.96 ± 0.20 and 1.67 ± 0.55, respectively). The joint-SUVmean and intra-articular SUVmax were higher in the group of radiological OA and the differences were statistically significant (p < 0.01 and p < 0.05, respectively) (Table 2).
Table 2

The differences of joint-SUVmean and intra-articular SUVmax by the evidences for knee OA

  

n

Age (yr)

BW (kg)

HT(cm)

BMI (kg/m2)

SUVmax

SUVmean

Knee + Symptom†

Total

62

57.5 ± 11.8

64.01 ± 1.1

162.6 ± 7.9

24.1 ± 3.3

1.73 ± 0.58**

0.95 ± 0.23

 

Male

24

56.0 ± 11.8

70.91 ± 2.1

170.6 ± 5.5

24.2 ± 3.2

1.77 ± 0.60

0.92 ± 0.21

 

Female

38

58.5 ± 11.8**

59.7 ± 8.1**

157.6 ± 4.2

24.1 ± 3.4**

1.69 ± 0.57**

0.96 ± 0.24**

Knee without Symptom

Total

104

53.9 ± 11.5

61.8 ± 12.0

163.2 ± 8.9

23.1 ± 3.2

1.49 ± 0.40

0.89 ± 0.19

 

Male

58

55.6 ± 12.3

68.7 ± 10.7

169.0 ± 6.4

23.9 ± 3.0

1.56 ± 0.41

0.95 ± 0.19

 

Female

46

51.8 ± 10.1

53.2 ± 7.1

155.8 ± 5.8

21.9 ± 2.9

1.40 ± 0.36

0.81 ± 0.15

Knee + OA history

 

20

64.6 ± 6.8**

63.0 ± 6.1

156.5 ± 2.9*

25.7 ± 2.7**

1.95 ± 0.57**

1.10 ± 0.24**

Clinical§ + laboratory OA

36

61.6 ± 9.9**

64.1 ± 8.1

162.3 ± 7.6

24.4 ± 2.9

1.80 ± 0.54**

0.99 ± 0.23**

Clinical + Radiographic§§ OA

71

59.5 ± 9.8**

64.0 ± 11.1

162.7 ± 7.9

24.1 ± 3.3

1.67 ± 0.55*

0.96 ± 0.20**

value = mean ± SD.

BW; body weight, HT; height, BMI; body mass index.

†; knee joint pain, stiffness, crepitus, bony enlargement and tenderness.

§; ≥ 2 of the symptoms‡.

§§; with definite osteophytes (≥ K/L grade II).

*; p < 0.05, ** ; p < 0.01.

As compared with those of the sex-matched groups without symptom.

As compared with those of the groups without OA history, clinico-laboratory or clinic-radiological OA.

Age and 18F-FDG uptake values showed a consistent increase with K/L grade of the knees. In addition, the increase of joint-SUVmean was significantly specific for bony changes and radiological OA of the knee.

18F-FDG uptake and clinical OA of knee joints

The joint-SUVmean and intra-articular SUVmax of knee joints were analyzed according to OA-related symptoms to determine whether the SUVs corresponded to clinical manifestations. OA-related symptoms and signs included knee joint pain, stiffness, crepitus, bony tenderness, and enlargement of the knee according to ACR criteria. They were counted from 0 to 5 in total. No symptoms were observed in 104 knees; 26 knees had one symptom; 12 knees had two symptoms; 12 knees had three symptoms; 10 knees had four symptoms, and two knees had five symptoms. The intra-articular SUVmax with no symptoms was 1.49 ± 0.40; 1.61 ± 0.62 with one symptom; 1.53 ± 0.48 with two symptoms; 1.77 ± 0.47 with three symptoms; 2.06 ± 0.59 with four symptoms; and 2.30 ± 0.42 with five symptoms. Difference among the groups by symptom count for OA was significant for BMI (p < 0.05) and the intra-articular SUVmax (p < 0.01), but not for the joint-SUVmean. However, the intra-articular SUVmax showed strong correlation with the joint-SUVmean (r = 0.659, p < 0.01) (Table 3, Figure 2).
https://static-content.springer.com/image/art%3A10.1186%2F1471-2474-14-141/MediaObjects/12891_2012_Article_1747_Fig2_HTML.jpg
Figure 2

The difference according to OA symptoms was significant in the intra-articular SUVmax. The intra-articular SUVmax showed positive correlation with the joint-SUVmean (A) in males (B) and females (C).

Table 3

The differences in joint-SUVmean and intra-articular SUVmax according to OA symptom count of the knees

 

Symptom count of the knee joints

p-value

 

0

1

2

3

4

5

n

104

26

12

12

10

2

 

Age (yr)

53.9 ± 11.5

51.9 ± 12.0

58.0 ± 3.6

66.5 ± 4.9

56.4 ± 13.3

81.0 ± 0.0

0.01*

BW (kg)

61.8 ± 12.0

63.9 ± 14.5

66.5 ± 7.9

61.2 ± 8.8

64.2 ± 7.9

67.0 ± 0.0

0.744

HT(cm)

163.2 ± 8.9

163.2 ± 8.5

161.7 ± 8.4

163.8 ± 5.6

162.6 ± 9.1

155.0 ± 0.0

0.836

BMI (kg/m2)

23.1 ± 3.2

23.8 ± 3.8

25.4 ± 2.4

22.8 ± 2.8

24.3 ± 2.9

27.9 ± 0.0

0.04*

SUVmax

1.49 ± 0.40

1.61 ± 0.62

1.53 ± 0.48

1.77 ± 0.47

2.06 ± 0.59

2.30 ± 0.42

0.01*

SUVmean

0.89 ± 0.18

0.88 ± 0.20

0.99 ± 0.25

0.90 ± 0.16

1.06 ± 0.29

1.15 ± 0.07

0.051

value = mean ± SD.

BW; body weight, HT; height, BMI; body mass index.

*; p < 0.05.

Because knees with positive RF, ESR higher than 40 mm/h, and palpable warmth were excluded from this study, those with more than two symptoms could be diagnosed as clinical and laboratory knee OA according to ACR criteria. Thirty six knees were included as clinical and laboratory OA; the joint-SUVmean and intra-articular SUVmax of the group were 0.99±0.23 and 1.80±0.54, respectively, which were significantly higher than 0.89±0.19 and 1.51±0.45 of the non-OA group of symptom count 0 and 1 (p < 0.05 and p < 0.01, respectively) (Table 2).

Twenty knees presented with a history of OA, the joint-SUVmean and intra-articular SUVmax were 1.10±0.24 and 1.95±0.57, respectively. The values were significantly higher, compared with 0.91±0.18 and 1.61±0.46, respectively, of the group without history of OA (p < 0.01 for both values) (Table 2).

The results may indicate that the increases of joint-SUVmean and intra-articular SUVmax are consistent with clinical and laboratory knee OA.

Changes of 18F-FDG uptake according to age and gender

Aging is one of the most important factors in development of OA. As the ACR suggests age above 50 as a criterion for diagnosis of OA, the values for 18F-FDG uptake were evaluated according to age. The SUVmean of knee joints showed a weak correlation with the advance of age (r = 0.326, p < 0.01); however, the joint-SUVmean and intra-articular SUVmax in knee joints over the age of 50 (n = 118, 0.94±0.20 and 1.64±0.50, respectively) were significantly higher than those of knee joints under 50 (n = 48, 0.82±0.19 and 1.42±0.41, respectively) (p < 0.01 and p < 0.05, respectively) (Table 4, Figure 3).
https://static-content.springer.com/image/art%3A10.1186%2F1471-2474-14-141/MediaObjects/12891_2012_Article_1747_Fig3_HTML.jpg
Figure 3

The SUVs were significantly correlated with age in OA. With increasing age, the Mean SUV of the knee joint increased independently of the presence of joint problems (A, B). The joint-SUVmean and intra-articular SUVmax showed significant positive correlation with age (C, D), even in the group without OA symptoms (E, F) and without evidence of radiographic OA (G, H). The SUVs adjusted for age and gender showed remarkable and significant correlations, especially in females (I, J).

Table 4

The joint-SUVmean and intra-articular SUVmax of knee joints in the groups over and under the age of 50

   

n

BW (kg)

HT(cm)

BMI (kg/m2)

Max SUV

SUVmean

Age (yr)

Total

≥ 50

118

61.9 ± 11.2

161.2 ± 7.8

23.7 ± 3.3

1.64±0.50*

0.94 ± 0.20**

  

< 50

48

65.6 ± 12.9

167.3 ± 8.9**

22.9 ± 2.9

1.42 ± 0.41

0.82 ± 0.19

 

Male

≥ 50

54

67.6 ± 1.5

167.9 ± 0.8

23.9 ± 0.5

1.68 ± 0.51

0.97 ± 0.18

  

< 50

28

72.6 ± 1.9

172.5 ± 1.1

24.3 ± 0.4

1.51 ± 0.43

0.90 ± 0.21

 

Female

≥ 50

64

57.0 ± 1.1

155.6 ± 0.5*

23.5 ± 0.4**

1.60 ± 0.50*

0.92 ± 0.21**

  

< 50

20

53.4 ± 1.5

160.0 ± 1.6

20.9 ± 0.6

1.31 ± 0.36

0.72 ± 0.09

value = mean ± SD.

BW; body weight, HT; height, BMI; body mass index.

*; p < 0.05, **; p < 0.01.

Body weight and BMI in females with symptomatic knee were significantly higher than in those without symptoms (p < 0.01, respectively). Knees with history of OA had significantly higher BMI and height than those without history of OA (p < 0.01, respectively) (Table 2).

As OA occurs more frequently in females, the intra-articular SUVmax and joint-SUVmean of 18F-FDG of 82 knees from 41 males and 84 knees from 42 females were evaluated for determination of the difference according to gender. Mean ages of males and females were 55.7±12.1 and 54.9±11.4, respectively (p = 0.59). The SUVmean in males was 0.94±0.19, significantly higher than 0.88±0.20 of females (p < 0.05). Even higher, the values showed no change by aging in males (r = 0.204, p = 0.06; r = 0.008, p = 0.297, respectively); however, in females, the joint mean and intra-articular SUVmax showed a significant increase in correlation with aging (r = 0.503, p < 0.01; r = 0.392, p < 0.01, respectively). The results may indicate that metabolic alteration represented by changes of 18F-FDG uptake is prominent in females, which is consistent with OA development in association with aging and gender.

Adjusted by linear regression analysis for age and gender, the 18F-FDG uptake showed an association of each one-year increase in age with a 0.006 increase in joint-SUVmean (β = 0.006, 95% CI, p < 0.01). The βcoefficient of joint-SUVmean adjusted by age and gender in clinico-laboratory and radiological OA was 0.008 (p = 0.002); female 0.009 (p = 0.008) and male 0.006 (p = 0.119), as compared with 0.002 (P = 0.287) in non-OA; female −0.00005 (p = 0.99), male 0.003 (p = 0.271) (Figures 3I,J). Results of the analyses indicated that increased joint-SUVmean in OA was not by aging, and joint-SUVmean in knee OA was related to aging, but not in non-OA, meaning that the significant correlations found between joint-SUVmean and clinic-laboratory and radiological knee OA persist, as compared to non-OA.

Discussion

ACR criteria for diagnosis of OA require more than three of the clinical-, radiological-, and laboratory criteria. In this study, symptomatic knees that met the ACR requirement for OA showed a significant increase of 18F-FDG uptake, and metabolic alteration represented by the change of SUVmean was consistent with a history of knee OA and clinical-, radiological knee OA. The intra-articular SUVmax showed positive correlation with the joint-SUVmean and showed a significant increase in association with joint symptoms indicating OA. The joint-SUVmean showed a significant increase according to the grades of radiological bony changes, and the values were higher in clinical-, laboratory, and radiological OA than those in non-OA.

PET provides molecular imagery of biochemical and metabolic changes and is supposed to overcome the limitations of anatomical imaging studies. Because it is able to illuminate whole body, PET has been widely used for detection and staging of malignancies. For PET imaging, 18F-FDG is one of the most commonly used radioisotopes. Because malignant tissues are active in metabolism, increased glucose uptake can be reflected by 18F-FDG uptake as a glucose analog [11]. Glucose taken up by cells is metabolized to glucose-6-phosphate and then to fructose-6-phosphate and fructose 1,6-biphosphonate; however, 18F-FDG-6-phosphate accumulates in the cell, which creates the images seen on the PET scan [12]. Increased metabolism associated with infection or inflammation can also be detected by PET using 18F-FDG; this allows for assessment for inflammatory bone and joint diseases, such as rheumatoid arthritis, psoriatic arthritis, and osteomyelitis [58]. OA accompanies metabolic alterations and inflammatory changes; therefore, increasing 18F-FDG uptake could be predicted in OA. Wandler et al., who evaluated the pattern and value of 18F-FDG uptake in shoulder joints, reported that the uptake pattern was diffuse, including the whole joint in patients with OA [13]. Nakamura et al. reported that 18F-FDG uptake was up-regulated in OA and generally accumulated in periarticular lesions [14].

Females are particularly prone to OA, with a risk twice as high as that of males. This has been thought to be associated with estrogen deficiency after menopause, which down-regulates the estrogen receptor on the surface of chondrocytes, resulting in decreased synthesis of proteoglycan [1517]. In this study, the SUVmean of knee joints was higher in males than in females, however, the changes of the values increased in strong correlation with aging in females, but not in males. This finding might indicate that although metabolic rate is higher in males than in females, the metabolic alteration by aging may be remarkable in females, which is consistent with OA. The differences according to age and gender showed agreement with the higher incidence of OA in aging females than in males.

The glycolysis and pentose phosphate pathways are major pathways of glucose metabolism, and the uronic acid pathway and hexosamine biosynthetic pathways are important for excretion of metabolites as glucuronides and for synthesis of amino-sugars such as glycosaminoglycans (GAGs) and proteoglycans (PGs). In addition to the metabolic pathways, glucose uptake and metabolism can be influenced by the oxygen tension of tissues, thus, decreased tissue perfusion and hypoxia could affect glucose uptake and metabolism by anaerobic glycolysis [18].

Intra-articular and peri-articular structures, including synovium, subchondral bone, ligaments, and synovial fluid, as well as cartilage, may be affected by and generate mechanical loads and soluble mediators directing chondrocytes to activation, cartilage to breakdown, and joints to degeneration [19]. Intra-articular reactions are very important in joint degeneration and pathogenesis of OA; therefore, because discrimination of the respective structures is difficult using PET and CT images, this study adopted intra-articular SUVmax for evaluation of the impact of focal intra-articular reactions on OA. In the current study, the SUVmean of knee joints for global joint metabolism might contain SUVs from peri-articular and intra-articular structures, including subchondral bones, and the intra-articular SUVmax for focal intra-articular reactions irrespective to the structures might involve uptake by synoviums, ligaments, and menisci as well as cartilage.

This study has a specific limitation related to assessment of bony changes of the knee. The K/L grading system of knee joints was originally based on X-ray images, however, in this study, K/L grades were used for the reconstructed CT images of the knee joints [9]. Despite the limitation, the images discriminated bony changes in association with OA and its severity. Even though the increase of joint-SUVmean can be related to direct damage/pathology of articular structures and it is not only related to aging, the change of joint-SUVmean as an indicator for metabolic alteration of knee joints is clearly correlated with presence and severity of primary OA and aging in OA, especially in females.

Conclusions

As a result of this study, it would be supposed that 18F-FDG uptake of PET scan is increased in OA and is consistent with development of OA. The clinical- and radiological evidence for OA and severity of OA consistently showed correlation with the increasing SUVs in association with aging in OA. Early detection for the changes can be a benefit of PET/CT in terms of OA. The 18F-FDG uptakes on PET/CT imaging may have capability for early detection of changes to OA beyond the radiological assessment that is critical to preventing progression to irreversible joint failure.

Abbreviations

F-FDG: 

18F-fluorodeoxyglucose

OA: 

Osteoarthritis

PET/CT: 

Positron emission tomography-computed tomography

SUVmax: 

Maximum standardized uptake values

SUVmean: 

Mean SUV

K/L grade: 

Kallgren-Lawrence grade

ACR: 

American College of Rheumatology

ESR: 

Erythrocyte sedimentation rate

RF: 

Rheumatoid factor

BW: 

Body weight

HT: 

Height

BMI: 

Body mass index

ROIs: 

Regions of interest

SUVs: 

Standardized uptake values

GAGs: 

Glycosaminoglycans

PGs: 

Proteoglycans.

Declarations

Acknowledgements

This work was supported by Yeungnam University Research Grant (No. 211-A-380062 to Hong YH). We thank Ye Lim Hong who assisted in copyediting.

Authors’ Affiliations

(1)
Department of Internal Medicine, Yeungnam University School of Medicine
(2)
Department of Nuclear Medicine, Yeungnam University School of Medicine

References

  1. Felson D: Epidemiology of hip and knee osteoarthritis. Epidemiol Rev. 1988, 10: 1-28.PubMed
  2. Buckwalter JA, Mankin HJ, Grodzinsky AJ: Articular cartilage and osteoarthritis. Instr Course Lect. 2005, 54: 465-480.PubMed
  3. Resnick D: Degenerative disease of extraspinal locations. Diagnosis of bone and joint disorder. 2002, Philadelphia: W.B. Saunders, 1271-1381. 4
  4. Inerot S, Heinegard D: Articular-cartilage proteoglycans in aging and osteoarthritis. Biochem J. 1978, 169: 143-156.PubMed CentralView ArticlePubMed
  5. Sugawara Y, Braun DK, Kison PV, Russo JE, Zasadny KR, Wahl RL: Rapiddetection of human infections with fluorine-18 fluorodeoxyglucose and positronemission tomography: preliminary results. Eur J Nucl Med. 1998, 25: 1238-1243. 10.1007/s002590050290.View ArticlePubMed
  6. Bakheet SM, Powe J: Fluorine-18-fluorodeoxyglucose uptake in rheumatoidarthritis–associated lung disease in a patient with thyroid cancer. J Nucl Med. 1998, 39: 234-236.PubMed
  7. Yun M, Kim W, Adam LE, Alnafisi N, Herman C, Alavi A: F-18 FDG uptake in apatient with psoriatic arthritis: imaging correlation with patient symptoms. Clin Nucl Med. 2001, 26: 692-693. 10.1097/00003072-200108000-00006.View ArticlePubMed
  8. Meller J, Koster G, Liersch T, Siefker U, Lehmann K, Meyer I: Chronicbacterial osteomyelitis: prospective comparison of 18F-FDG imaging with a dualheadcoincidence camera and (111)In-labeled autologous leucocyte scintigraphy. Eur J Nucl Med Mol Imag. 2002, 29: 53-60. 10.1007/s00259-001-0661-9.View Article
  9. Johnston JD, McLennan CE, Hunter DJ, Wilson DR: In vivo precision of a depth-specific topographic mapping technique in the CT analysis of osteoarthritic and normal proximal tibial subchondral bone density. Skeletal Radiol. 2011, 40: 1057-1064. 10.1007/s00256-010-1001-6.View ArticlePubMed
  10. Kellgren JH, Lawrence JS: Radiological assessment of osteoarthritis. Ann Rheum Dis. 1957, 16: 494-502. 10.1136/ard.16.4.494.PubMed CentralView ArticlePubMed
  11. Brown RS, Wahl RL: Overexpression of Glut-1 glucose transporter in humanbreast cancer. An immunohistochemical study. Cancer. 1993, 72: 2979-2985. 10.1002/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X.View ArticlePubMed
  12. Wahl RL: Principle and practice of positron emission tomography. 2002, Philadelphia: Lippincott Williams & Willkins
  13. Wandler E, Kramer EL, Sherman O, Babb J, Scarola J, Rafii M: Diffuse FDGShoulder Uptake on PET Is Associated with Clinical Findings of Osteoarthritis. Am J Roentgenol. 2005, 185: 797-803. 10.2214/ajr.185.3.01850797.View Article
  14. Nakamura H, Masuko K, Yudoh K, Kato T, Nishioka K, Sugihara T: Positronemission tomography with 18F-FDG in osteoarthritic knee. Osteoarthr Cartil. 2007, 15: 673-681. 10.1016/j.joca.2006.12.010.View ArticlePubMed
  15. Wluka AE, Cicuttini FM, Spector TD: Menopause, oestrogens and arthritis. Maturitas. 2000, 35: 183-199. 10.1016/S0378-5122(00)00118-3.View ArticlePubMed
  16. Pelletier G, El-Alfy M:Immunocytochemical localization of estrogen receptorsalpha and beta in human reproductive organs. J Clin Endocrinol Metab. 2000, 85: 4835-4840. 10.1210/jc.85.12.4835.PubMed
  17. Richmond RS, Carlson CS, Register TC, Shanker G, Loeser RF: Functionalestrogen receptors in adult articular cartilage: Estrogen replacement therapyincreases chondrocyte synthesis of proteoglycans and insulin-like growth factorbinding protein 2. Arthritis Rheum. 2000, 43: 2081-2090. 10.1002/1529-0131(200009)43:9<2081::AID-ANR20>3.0.CO;2-I.View ArticlePubMed
  18. Mayes PA: Glycolysis & the oxidation of pyruvate. Harper’s biochemistry. Edited by: Murray RK, Granner DK, Mayes PA, Rodwell VW. 1988, Norwalk, Connecticut/San Mateo, California: Appleton & Lange, 158-164.
  19. Pearle AD, Warren RF, Rodeo SA: Basic science of articular cartilage and osteoarthritis. Clin Sports Med. 2005, 24: 1-12. 10.1016/j.csm.2004.08.007.View ArticlePubMed
  20. Pre-publication history

    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2474/14/141/prepub

Copyright

© Hong and Kong; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.